2005
DOI: 10.1177/0310057x0503300116
|View full text |Cite
|
Sign up to set email alerts
|

Disease Risk and Mortality Prediction in Intensive Care Patients with Pneumonia. Australian and New Zealand Practice in Intensive Care (ANZPIC II)

Abstract: This study of ventilated patients investigated pneumonia risk factors and outcome predictors in 476 episodes of pneumonia (48% community-acquired pneumonia, 24% hospital-acquired pneumonia, 28% ventilator-associated pneumonia) using a prospective survey in 14 intensive care units within Australia and New Zealand. For community acquired pneumonia, mortality increased with immunosuppression (

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
20
0

Year Published

2005
2005
2022
2022

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 28 publications
(21 citation statements)
references
References 52 publications
1
20
0
Order By: Relevance
“…Comparisons and contrasts between CAP, HAP and VAP are limited. This study and its companion studies describe the clinical practice, disease risk 16 , outcome predictors 16 and factors affecting clinical decision making 17 for pneumonia managed in Australian and New Zealand ICUs.…”
Section: Discussionmentioning
confidence: 99%
“…Comparisons and contrasts between CAP, HAP and VAP are limited. This study and its companion studies describe the clinical practice, disease risk 16 , outcome predictors 16 and factors affecting clinical decision making 17 for pneumonia managed in Australian and New Zealand ICUs.…”
Section: Discussionmentioning
confidence: 99%
“… 11–15 This is reflected in lack of consensus about the diagnosis of VAP in Australia and New Zealand, 16 with few healthcare facilities routinely collecting VAP data. 17 While a 2005 study across 14 ICUs revealed a rate of 28%, 18 bi-national rates are currently unknown. Effective and systematic VAP prevention strategies are limited by this lack of consensus.…”
Section: Introductionmentioning
confidence: 99%
“…Although the SOFA score was not intended to predict mortality, it has been used for this purpose. Its simplicity and efficacy when compared to much more complex and sophisticated prognostic scoring systems (1)(2)(3)(4)(5)(6)(7)(8)(9) have led to its recent popularity and more frequent use beyond the sepsis setting for which it was originally developed [10][11][12][13][14][15] . More recently, the SOFA has been compared to other scores such as the APACHE and SAPS to evaluate patients with hematological malignancies and performed satisfactorily [16][17][18] .…”
Section: Introductionmentioning
confidence: 99%